Pacer Advisors, Inc. Myriad Genetics Inc Transaction History

Pacer Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$17.98 - $25.47 $11,291 - $15,995	-628 Reduced 54.14%	532 $13,000
Q1 2024 May 10, 2024	BUY	$17.59 - $23.59 $20,404 - $27,364	1,160 New	1,160 $24,000
Q2 2021 Jul 21, 2021	SELL	$25.39 - $32.61 $63,728 - $81,851	-2,510 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$19.92 - $31.6 $7,888 - $12,513	-396 Reduced 13.63%	2,510 $76,000
Q4 2020 Jan 20, 2021	SELL	$12.16 - $19.77 $35,701 - $58,044	-2,936 Reduced 50.26%	2,906 $57,000
Q3 2020 Oct 19, 2020	BUY	$11.25 - $14.75 $65,722 - $86,169	5,842 New	5,842 $76,000
Q4 2018 Feb 13, 2019	SELL	$27.23 - $45.56 $139,962 - $234,178	-5,140 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $193,109 - $258,747	5,140 New	5,140 $236,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $44,067 - $63,789	-1,588 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $13,319 - $18,946	-462 Reduced 22.54%	1,588 $47,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $58,322 - $76,137	2,050	2,050 $70,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.